Holmium laser enucleation of the prostate (HoLEP) with MOSES™ 2.0 Technology
If you’ve tried other options and they are no longer working, it may be time to consider an alternative.
What is HoLEP?
HoLEP is an outpatient procedure that uses a laser to cut away the enlarged prostate tissue causing obstruction. Tissue is then removed using a morcellator.
MOSES 2.0 Technology suits a majority of patients regardless of prostate size, anticoagulants therapy and age.4-6
Is HoLEP right for me?
The best way to find out is by talking with your doctor to determine if HoLEP is a suitable treatment for you based on your symptoms and treatment goals. Start by taking our BPH Quiz. Then bring a printout of the results with you to your appointment.
What are the risks?
The Lumenis Pulse™ 120H Laser System with delivery devices and accessories are intended for use in surgical procedures involving treatment for an enlarged prostate, soft tissue, and kidney stones in the medical specialty of urology. This device should not be used in patients who have prostate cancer.
With all medical procedures, there are risks associated with the procedure and the use of this device. The risks include but are not limited to unintended damage to structures near the surgical area (bowel, bladder, ureters and nerves), fever, bleeding, pain, inflammation, scarring, perforation of urinary tract structures or structures near the surgical area, and infection which can become severe. Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the use of the device.
Find a Doctor
Use our Doctor Finder to get in contact with Urologists who specialize in diagnosing and treating male urinary conditions like BPH.
*Reoperation as a result of recurrent obstruction from residual adenoma.
Reference
- Elmansy HM, Kotb A, Elhilali MM. Holmium laser enucleation of the prostate: long-term durability of clinical outcomes and complication rates during 10 years of followup. J Urol. 2011;186:1972–1976.Madersbacher S, Lackner J, Brössner C, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23, 123 cases. Eur Urol. 2005 Apr;47(4):499–504.
- Elshal AM, Mekkawy R, Laymon M et al. Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia; is it a realistic endourologic alternative in developing country? World J Urol. 2016 Mar;34(3):399–405.
- Michalak J, Tzou D, Funk J. HoLEP: the gold standard for the surgical management of BPH in the 21(st) Century. Am J Clin Exp Urol. 2015 Apr 25;3(1):36–42.
- Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA Guideline 2021. J Urol. 2021 Oct;206:806–26.
- Tamalunas A, Westhofen T, Schott M, et al. The clinical value of holmium laser enucleation of the prostate in octogenarians. Low Urin Tract Symptoms. 2021 Apr;13(2):279–285.
- Agarwal DK, Large T, Stoughton CL, et al. Real-World Experience of Holmium Laser Enucleation of the Prostate with Patients on Anticoagulation Therapy. J Endourol. 2021 Jul;35(7):1036–41.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Content of this web site is for Informational Purposes only and does not constitute medical advice and should not be used for medical diagnoses. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any clinical/medical questions.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
TreatMyBPH.com is a website owned by Boston Scientific.